定义
美国FDA 物质登记 · UNII 11JIB0YI93 · 登记名称 DIMETHYL ITACONATE · 单一化学物质
Dimethyl Itaconate is the organic compound that conforms to the formula
化妆品中的作用
延缓产品因氧化变质ANTIOXIDANT不属于以上类别的皮肤调理SKIN CONDITIONING - MISCELLANEOUS保护肌肤免受外界刺激SKIN PROTECTING柔顺头发HAIR CONDITIONING
安全与法规参考
未列入韩国有毒物质 GHS 分类 · 现有化学物质
详细资料——标示名称、识别编号、物性、试验记录、文献
别名和识别信息
DIMETHYL ITACONATEINCI다이메틸이타코네이트韩国标示名称(食药处标准名)
- CAS No.化学物质登记号
- 617-52-7
- EC No.欧盟化学品目录编号
- 210-519-6
- DTXSID美国EPA化学品编号
- DTXSID80210701
- DTXCID美国EPA化合物编号
- DTXCID70133192
- IUPAC
- Dimethyl 2-methylidenebutanedioate
- 分子式
- C7H10O4
- 分子量
- 158.153 g/mol
实测物性
- 熔点/凝固点
- 38 ℃(EXP)
- 初沸点和沸程
- 208 ℃(EXP)
- 闪点
- 100 ℃(c.c)
- 溶解度
- 14030 ㎎/ℓ
- 比重
- 1.1241 ( at 18℃)
- 正辛醇/水分配系数(Kow)
- 0.820 (估算值)
- 分子量
- 158.152
这是对物质本身测得的数值。韩国安全保健公团(KOSHA)的资料仅供编写和审核安全数据表参考,并非原料商品的规格。
来源: 韩国安全保健公团 安全数据表
刺激与致敏试验记录
记录有皮肤试验 5 项、眼部试验 4 项。
归类为刺激性高3 项归类为中等1 项
试验结论基本一致(75%)。 这是对原料本身的试验记录,与成品中所含浓度下的刺激性不同。
查看全部 9 项试验
- Severe Irritation
skin corrosion: in vitro / ex vivo · Screening · OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method) adopted 22 July 2010 according to EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test) according to - Corrosive
skin corrosion: in vitro / ex vivo · Screening · EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test) Official Journal of the European Union No. L142; Amended by EC No. 640/2012 OJ No. L193, 20 July 2012 ( (EpiSkin model)) according to OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method) adopted 26 July 2013 (EpiSkin model) according to - SkinSens1
Skin Sensitization · QSAR Predicted - High Frequency of Sensitization
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) as at 2002 according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) as at 2008 according to EPA OPPTS 870.2600 (Skin Sensitisation) as at 2003 - Low to Moderate Frequency of Sensitization
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: FAMIC according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to EPA OPPTS 870.2400 (Acute Eye Irritation) according to - Corrosive or Irritation Persists for > 21 days
eye irritation: in vitro / ex vivo · Screening · OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants) [before 26 July 2013] according to EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants) according to - Corrosive or Irritation Persists for > 21 days
eye irritation: in vitro / ex vivo · Screening · other guideline: OECD Guideline no. 437: "Bovine corneal opacity and permeability (BCOP) test method for identifying ocular corrosives and severe irritants" (adopted September 07, 2009) according to - Moderate or Mild Irritation
eye irritation: in vitro / ex vivo · Screening · OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants) [before 26 July 2013] according to EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants) according to
来源: 美国EPA CompTox
相关文献
- Dimethyl itaconate suppresses dendritic cell and CD8+ T cell responses to halt vitiligo · 2025
- ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives · 2022
- Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata · 2022
- Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis · 2020
- Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis · 2020